Phase I Trial of Intratumoral Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta in Patients With Sorafenib Refractory/Intolerant Hepatocellular Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs RVSV-interferon-beta (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 01 Oct 2020 Biomarkers information updated
- 10 Oct 2012 New source identified and integrated (Mayo Clinic).
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.